Treatment of Chronic Portal Vein Thrombosis in Cirrhosis with Portal Hypertension Complications
Clinical Scenario
This protocol addresses patients with liver cirrhosis who have chronic portal vein thrombosis — thrombosis present or persistent for more than 6 months — alongside complications of portal hypertension.
The relevant complications in this setting include variceal bleeding, refractory ascites, and hepatic hydrothorax.
Cirrhosis + Chronic PVT
Why This Combination Matters
When chronic portal vein thrombosis develops in the context of cirrhosis, it compounds the sequelae of portal hypertension. The co-occurrence of thrombosis and cirrhosis defines a specific sub-population for whom a targeted endovascular management strategy is supported by major guidelines, including Baveno VII and the ACG.
Management Approach — Overview
In this setting, the mainstay of endovascular management involves a portal vein–directed shunt-based procedure. This approach is particularly supported in patients with ongoing portal hypertension complications and in those listed for liver transplantation.
The complete structured regimen — including specific procedural details and guideline-based decision steps — is available in the full protocol.
References
DOI: 10.1016/j.tvir.2025.101084
- In the setting of chronic PVT secondary to cirrhosis, the mainstay of endovascular management is the creation of a transjugular intrahepatic portosystemic shunt with portal vein recanalization (PVR-TIPS).
- The Baveno VII consensus guidelines state that TIPS creation is recommended in patients with thrombosis of the portal vein trunk without recanalization on anticoagulation, especially in patients listed for liver transplant.
- The ACG also recommends consideration of TIPS placement in patients with PVT and sequelae of portal hypertension, including variceal bleeding, refractory ascites, and hepatic hydrothorax.
- Chronic PVT present or persistent for >6 months.
View source ↗